Investigators found SARS-CoV-2 "on various hospital objects, and these surfaces can be sources of nosocomial transmission via direct contact. Therefore, our findings provide an important basis for justification of strict contact precaution.”
Hospital rooms treating patients with, or suspected of having, coronavirus disease 2019 (COVID-19), need to be handled with special care when it comes to cleaning and disinfecting. That’s not much debated these days, and a recent study in the American Journal of Infection Control reinforces the importance of strict contact precaution, routine cleaning, and disinfection when it comes to surfaces in those rooms.
Education about infection prevention and maintaining adequate supplies of personal protective equipment (PPE)—two areas of focus for infection preventionists—also plays a part, according to investigators with the Gyeongsang National University Changwon Hospital, Changwon, in South Korea, who conducted the study.
For instance, they note that the standard cleaning procedures include using solutions made up of 0.1% hypochlorite. “However, due to the shortage of personal protective equipment (PPE) and vague fears of cleaners, room cleaning, and disinfection were not performed every day,” the study states.
The data come from 13 patients with COVID-19 who were admitted to two hospitals in South Korea in March. The hospitals are identified as Hospital A and B. Hospital A had 5 patients, 2 of whom with severe pneumonia and who needed oxygen, were sent to negative pressure rooms off of the intensive care unit (ICU). The other 3 patients were admitted to negative pressure rooms in the isolation ward.
Meanwhile, in Hospital B, 8 asymptomatic patients were admitted to 2 common 4-bed rooms without negative pressure or ventilation systems. The beds were placed in the four corners of the room and divided by curtains.
“Environmental samples were collected from each patient’s room and ancillary spaces, such as the anteroom, adjacent common corridor, and nursing station,” the study states. “Dacron swabs premoistened with viral transport medium … were used to swab environmental surfaces aseptically.”
The surfaces tested included: patient monitor, ventilator monitor, blood pressure cuff, pillow, suction bottle and line, infusion pump, fluid stand, door button or knob, bedside rail, head and foot of the bed, nurse call controller, lower part of the window frame, top of the television, air exhaust damper, wall and floor of the room, toilet paper holder, and inside and seat of the toilet. Surfaces in anterooms were also tested, such as door buttons, computer keyboard and mouse, and the floor. The nurse station surfaces were tested as well (counter, interphone, keyboard, computer mouse, chair, and floor).
“In Hospital A, SARS-CoV-2 was detected in 10 of 57 (17.5%) samples from inside the rooms including the Ambu bag and infusion pump,” the study states. “Two samples obtained at more than 2 m from the patients showed positive results. In Hospital B, 3 of 22 (13.6%) samples from inside the rooms were positive. Areas outside the rooms, such as the anteroom, corridor, and nursing station, were all negative in both hospitals.”
The investigators conclude: “Our results clearly show environmental contamination of the COVID-19 patients’ surroundings by SARS-CoV-2. Indeed, viruses have been found on various hospital objects, and these surfaces can be sources of nosocomial transmission via direct contact. Therefore, our findings provide an important basis for justification of strict contact precaution.”
The Role of Environmental Hygiene in Preventing Antimicrobial Resistance
March 19th 2024Uncover the pivotal role of environmental hygiene in thwarting antimicrobial resistance (AMR) for infection prevention teams. Learn how rigorous cleaning protocols and advanced technologies enhance patient safety and combat AMR.
Four Years After COVID-19: What Has the Infection Prevention Community Learned?
March 15th 2024Four years ago today, March 15, 2020, the COVID-19 lockdown began, and since then, the world has undergone significant changes. It has been a terrifying experience for everyone, especially for the infection prevention community, both within and outside of the health care sector. However, a crucial question remains unanswered: What has the infection prevention community learned from this pandemic, and where does it go from here?
COVID-19 Harmonization: Balancing Risks and Benefits of CDC's Latest Move
March 11th 2024The CDC's recent decision to align recommendations for respiratory viruses, particularly COVID-19, has garnered support from the public and infectious disease societies. However, as the Infectious Diseases Society of America (IDSA) lends its backing to the CDC's harmonization efforts, concerns persist regarding the implications of this shift, especially considering the Omicron variant's unique characteristics and the ongoing challenges posed by COVID-19's multi-system impacts.
Voices of Resilience: Q&A With the Editor of "Corona City: Voices From an Epicenter"
March 1st 2024Step into the diverse and poignant world of "Corona City: Voices From an Epicenter" with editor Lorraine Ash, MA. In this insightful Q&A, learn about the origins of this remarkable anthology, the challenges faced in capturing raw, unfiltered narratives of the COVID-19 pandemic, and the lasting impact of these stories on readers and communities alike.
Rare Disease Day 2024: Spotlight on Rare Infectious Diseases
February 29th 2024Rare Disease Day on February 29, 2024, shines a global light on the impact of rare diseases, including rare infectious diseases. With a focus on early diagnosis and treatment access, this day highlights the struggles of those with rare conditions.
COVID-19 Realities: Beyond a Respiratory Virus, Addressing Optimism in Pandemic Management
February 28th 2024A recent commentary by Dr. Amesh Adalja in MedPage Today challenges the perception of COVID-19 as solely a respiratory virus, highlighting its broader impact on the body. This analysis questions the notion that COVID-19 should be managed like common respiratory infections, urging a closer look at vaccine effectiveness, the rise of long COVID, and the need for enhanced measures to curb the virus's spread. Let's explore the complexities of COVID-19 management and the pressing realities faced by the US and the world.